Home -> Law Blog Directory -> Patent Law Blogs -> Patently Obvious
(866) 635-2689 for Personal Injury or (866) 635-9402 for Criminal Defense
Find a Local Lawyer
Divorce (866) 635-6190
Personal Injury (866) 635-2689
Criminal Defense (866) 635-9402
Patent Law
: Patently ObviousPatent Appeals: The Elements of Effective Advocacy in the Federal Circuit
By Dennis Crouch, Esq.
Book: Patent Appeals: The Elements of Effective Advocacy in the Federal Circuit
Author: Mark Davies
Publisher: Oxford University Press
Cost: $85.00 from Amazon
Mark Davies recently authored the user manual for Federal Circuit appeals. From its 300 spiral-bound pages, you can tell that the book is designed to serve the appellate attorney during the process of crafting a brief. Davies argued dozens of appeals as a DOJ appellate attorney and is now doing the same at O’Melveny in DC.
The book is very easy to read and understand, and it does an especially good job of providing concrete advice on how to draft an effective and clearly written brief while staying within the rules.
Davies adapts Strunk & White’s Elements of Style into a top five list that would benefit any writing: (1) Omit needless words; (2) Make the paragraph the unit of composition; (3) Use parallel and consistant writing form; (4) Use the active voice; and (5) Use definite, specific, concrete language.
His biggest general piece of advice is in all caps: DO NOT USE A DISTRICT COURT BRIEF AS A SHELL!
If you have an appeal pending, you better use the book.
Full post as published by Patently Obvious on July 20, 2008 (boomark / email).
Book Review Monday: Patent Appeals
The book “Patent Appeals: The Elements of Effective Advocacy in the Federal Circuit” by Mark Simon Davies (Oxford University Press, USA) provides detailed guidance for IP lawyers on the requirements for an appellate brief set out in the Federal Rules of Appellate Procedure 28(a)...
Federal Circuit Patent Mediation Success Rate at 42%
Statistics on the activities of the Circuit Mediation Office, including number of appeals brought into mediation, numbers of appeals settled, both patent and non-patent, and success rate are available at this link, listing through December 31, 2007,Appeals settled: 39Patent: 34Non-patent: 5 Appeals not settled; mediation terminated: 53Patent: 43Non-patent: 10 Success rate - overall: 42%Patent: 42%Non-patent: 33%
"Patent Appeals Board Constitutionality Targeted in Federal Circuit"
"Patent Appeals Board Constitutionality Targeted in Federal Circuit": Mike Scarcella has this post today at "The BLT: The Blog of Legal Times."
Federal appeals court backs new sentencing hearing for Mumia Abu-Jamal
[JURIST] Journalist and former Black Panther Mumia Abu-Jamal [advocacy website; Philadelphia Inquirer archive], convicted in 1982 of killing Philadelphia police officer Daniel Faulkner [advocacy website] after a traffic stop, may escape the death penalty after the US Court of Appeals for the Third Circuit on Thursday issued an opinion [PDF text] affirming a federal judge's allowance of a new
Lovenox Patent Case Back at Federal Circuit; Generic Versions Still Not Yet Approved
Guest post by Robert S. Dailey The Lovenox patent infringement litigation between Aventis and Teva/Amphastar is making its second trip to the Federal Circuit. In February, following remand from the Federal Circuit last year, a federal district court in California...
The PACER U.S. Party Case Index Now Includes All Federal District and Bankruptcy Courts
So what federal courts are currently not available on the USPCI? U.S. COURT OF APPEALS, SECOND CIRCUIT U.S. COURT OF APPEALS, FIFTH CIRCUIT U.S. COURT OF APPEALS, SEVENTH CIRCUIT U...
Privacy Protection Act 42 USC 21A
Federal Newsroom Law
Federal Adoption Tax Credit
Financial Incentive for Adoptive Parents
Transportation Equity Act for the 21st Century
TEA-21 - Plus Law 105-178
Miralus Inc.
alleging HeadOn is not safe or effective.
Specialty Lamp International
Recalls Counterfeit Circuit Breakers
Personal Injury
Appeals Court Upholds Congressional Legislation
Zantac Patent
GlaxoSmithKline and Cypress Pharmaceutical settle patent infringement dispute.
Soliris Patent
Alexion Pharmaceuticals Inc. agrees to pay the Oklahoma Medical Research Foundation a $10 million patent infringement settlement.
DRAM Patent
ProMOS Technologies and Mosel Vitelic pay MOSAID Technologies an undisclosed patent infringement settlement.
#1 Online Legal Resource
On 08-25 at 15:46PM
Acute perpendicular parking #NYPD #NYFD
On 08-18 at 22:18PM
Parallel parking gone bad. Too much gas UES NYC
On 08-18 at 21:41PM
UES NYC
On 08-18 at 21:25PM
Twitter suspends journalist critical of broadcast partner's coverage on dubious grounds @guyadams #nbcfail #twitterfail
On 07-30 at 17:57PM
Model example of 1st Amendment suppression by the People of New York City's Michael Bloomberg #OWS #NYPD
On 07-12 at 21:07PM
AG Holder lackadaisical on Operation in our Sites domain name seizures & RIAA lobbied free speech suppression @dajaz1
On 06-08 at 22:44PM
Why is the Catholic Church going to court over Obama contraception policy? @NewYorker commentary
On 05-31 at 10:08AM
Monks sue Louisiana for right to sell caskets made from forrest destroyed by Katrina
On 05-31 at 07:47AM
Are the abortion ultrasound laws headed for the Supreme Court?
On 05-15 at 21:52PM
 |
|
Contact Us | About Us | Celebrity Law Blog |
Our Partners | Disclaimer
| Law Blog Directory
| Law Jobs
| Law Tweets
| Oil Spill Video
All original material © 1999-2011 by USLaw.com. All other material, including Blog Directory feed content, are © by their respective copyright holders. |